EMA All Set To Oversee Use Of COVID-19 Treatments, Vaccines In Clinical Practice

Three Observational Research Projects Were Signed In Three Months

The European Medicines Agency has finalized infrastructure to monitor the safety and effectiveness of COVID-19 medicines and vaccines when they are used in day-to-day clinical practice following marketing authorization.

Analytics
Observational Research Is A Key Pillar Of Postmarket Surveillance • Source: Shutterstock

More from Real-World Evidence

More from Clinical Trials